FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage
FDA's 180-day exclusivity rewards the first generic drug maker to challenge a patent, but delays and deals have turned it into a tool for market control. Here's how it works - and why reform is coming.